Literature DB >> 19479371

CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population.

Majid Shahbazi1, Hamid Ebadi, Davood Fathi, Danial Roshandel, Mana Mahamadhoseeni, Azam Rashidbaghan, Narges Mahammadi, Mahammad Reza Mahammadi, Mahdi Zamani.   

Abstract

The 32-base pair deletion on the C-C chemokine receptor 5 gene (CCR5-delta 32) is known as a protective allele against immune system disorders. We have studied this variation in Iranian multiple sclerosis (MS) patients and healthy controls. DNA samples were prepared from the whole blood of 254 patients with MS and 380 healthy controls. We amplified the fragment including the CCR5-delta 32 polymorphism and visualized the products in a documentation system after agarose gel electrophoresis. Data were analysed using one-way ANOVA and Fisher's exact tests with SPSS-v13 and STATA-v8 software. The delta 32 allele was more frequent in MS patients when compared with controls (OR = 2.3, P < 0.0001). Also, we found a significant difference in the frequency of the delta 32/delta 32 genotype among patients and controls (OR = 7.4, P < 0.001). The mean age at onset and progression index was not significantly different between patients with various genotypes. According to our study, the delta 32 allele of the CCR5 gene might be a predisposing factor for MS development in the Iranian population. However, there were no associations between this polymorphism and the clinical course of the disease in this study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19479371     DOI: 10.1007/s10571-009-9415-1

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  30 in total

Review 1.  Chemokines and disease.

Authors:  C Gerard; B J Rollins
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

Authors:  D A Duszczyszyn; J D Beck; J Antel; A Bar-Or; Y Lapierre; V Gadag; D G Haegert
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Identification of a major co-receptor for primary isolates of HIV-1.

Authors:  H Deng; R Liu; W Ellmeier; S Choe; D Unutmaz; M Burkhart; P Di Marzio; S Marmon; R E Sutton; C M Hill; C B Davis; S C Peiper; T J Schall; D R Littman; N R Landau
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

4.  Association between functional polymorphism in EGF gene and malignant melanoma.

Authors:  Majid Shahbazi; Vera Pravica; Najma Nasreen; Hana Fakhoury; Anthony A Fryer; Richard C Strange; Peter E Hutchinson; Joy E Osborne; John T Lear; Andrew G Smith; Ian V Hutchinson
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

5.  CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.

Authors:  Orhun H Kantarci; Yazmín Morales; Patricia A Ziemer; David D Hebrink; Don J Mahad; Elizabeth J Atkinson; Sara J Achenbach; Mariza De Andrade; Matthias Mack; Richard M Ransohoff; Hans Lassmann; Wolfgang Bruck; Brian G Weinshenker; Claudia F Lucchinetti
Journal:  J Neuroimmunol       Date:  2005-09-22       Impact factor: 3.478

6.  Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.

Authors:  J Simpson; P Rezaie; J Newcombe; M L Cuzner; D Male; M N Woodroofe
Journal:  J Neuroimmunol       Date:  2000-08-01       Impact factor: 3.478

7.  Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence.

Authors:  A F Alshubaili; K Alramzy; Y M Ayyad; Y Gerish
Journal:  Eur Neurol       Date:  2005-04-28       Impact factor: 1.710

8.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

9.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  9 in total

Review 1.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

2.  CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients.

Authors:  Rosalia D'Angelo; Concetta Crisafulli; Carmela Rinaldi; Alessia Ruggeri; Aldo Amato; Antonina Sidoti
Journal:  Mult Scler Int       Date:  2011-06-23

Review 3.  The frequency of CCR5 promoter polymorphisms and CCR5 Δ 32 mutation in Iranian populations.

Authors:  Mohammad Zare-Bidaki; Masoud Karimi-Googheri; Gholamhossein Hassanshahi; Nahid Zainodini; Mohammad Kazemi Arababadi
Journal:  Iran J Basic Med Sci       Date:  2015-04       Impact factor: 2.699

4.  Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran.

Authors:  Zahra Heydarifard; Alijan Tabarraei; Abdolvahab Moradi
Journal:  Dis Markers       Date:  2017-10-25       Impact factor: 3.434

5.  CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients

Authors:  Reza Abdolmohammadi; Saleh Shahbazi Azar; Ayyoob Khosravi; Majid Shahbazi
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

6.  Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China.

Authors:  Chan Zhang; Yan He; Ke-Ren Shan; Kui Tan; Ting Zhang; Chan-Juan Wang; Zhi-Zhong Guan
Journal:  J Int Med Res       Date:  2017-09-20       Impact factor: 1.671

7.  Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.

Authors:  Majid Shahbazi; Javad Sadeghi Allah Abadi; Danial Roshandel; Maryam Koochaki; Hosein Amiri; Rahim Kohansal; Seied Mohammad Baghbanian; Mahdi Zamani
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

8.  Prevalence of CCR5delta32 in Northeastern Iran.

Authors:  Amir Tajbakhsh; Mostafa Fazeli; Mehdi Rezaee; Faezeh Ghasemi; Mastoureh Momen Heravi; Aida Gholoobi; Zahra Meshkat
Journal:  BMC Med Genet       Date:  2019-11-15       Impact factor: 2.103

9.  Association of Multiple Sclerosis Phenotypes with Single Nucleotide Polymorphisms of IL7R, LAG3, and CD40 Genes in a Jordanian Population: A Genotype-Phenotype Study.

Authors:  Laith Al-Eitan; Malak Al Qudah; Majdi Al Qawasmeh
Journal:  Biomolecules       Date:  2020-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.